Ocuphire Pharma Inc. buy Cantor Fitzgerald
Start price
14.08.23
/
50%
€3.83
Target price
14.08.24
€15.55
Performance (%)
-72.32%
End price
15.08.24
€1.06
Summary
This prediction ended on 15.08.24 with a price of €1.06. The BUY prediction by Cantor_Fitzgerald for Ocuphire Pharma Inc. performed very badly with a performance of -72.32%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocuphire Pharma Inc. | 42.343% | 42.343% | 156.007% |
| iShares Core DAX® | 1.301% | -1.386% | 12.259% |
| iShares Nasdaq 100 | 0.612% | -4.172% | 1.687% |
| iShares Nikkei 225® | 8.772% | 9.777% | 30.041% |
| iShares S&P 500 | 0.254% | -2.301% | 0.794% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $17.00 price target on the stock.
Ratings data for OCUP provided by MarketBeat
In the thread Trading Ocuphire Pharma Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten